Oropharyngeal Gram-negative bacillary carriage in chronic obstructive pulmonary disease: Relation to severity of disease

Respiratory Medicine

Volumn 93, Issue 8, 1999, Pages 540-545

  Mobbs, K J ^a   Van Saene, H K F ^a   Sunderland, D ^a   Davies, P D O ^b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b Broad Green Hospital   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL OVERGROWTH; BACTERIUM CARRIER; BACTERIUM CULTURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DISEASE SEVERITY; ENDOTRACHEAL INTUBATION; FEMALE; FORCED EXPIRATORY VOLUME; GRAM NEGATIVE BACTERIUM; HUMAN; INFECTION; MALE; OROPHARYNX; PNEUMONIA; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS;

EID: 0032876642     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0954-6111(99)90152-X     Document Type: Article

References (32)

1. van Saene HKF, Stoutenbeek CP, Torres A. The abnormal oropharyngeal carrier state: symptom or disease? Respir Med 1992; 86: 183-186.
2. Johanson WG, Pierce AK, Sanford JP. Changing pharyngeal flora of hospitalised patients. N Engl J Med 1969; 281: 1137-1140.
3. Garrouste-Orgeas M, Marie O, Rouveau M, et al. Secondary carriage with Acinetobacter baumannii and Klebsiella pneumoniae in an adult ICU population: relationship with nosocomial infections and mortality. J Hasp Infect 1996; 34: 279-289.
4. Lortholary O, Fagon JY, Buu Hoi A, et al. Nosocomial acquisition of multi-resistant Acinetobacter baumannii: risk factors and prognosis. Clin Infect Dis 1995; 20: 790-796.
5. Lees AW, McNaught W. Bacteriology of lower-respiratory-tract secretions, sputum, and upper-respiratory-tract secretions in "normals" and chronic bronchitics. Lancet 1959; ii: 1112-1115.
6. Butt HL, Clancy RL, Cripps AW et al. Bacterial colonisation of the respiratory tract in chronic bronchitis. Aust NZ J Med 1990; 20: 35-38.
7. Sachs APE, van der Waaij D, Groenier KH et al. Oropharyngeal flora in asthma and in chronic obstructive pulmonary disease. Am Rev Respir Dis 1993; 148: 1302-1307.
8. Siafakas NM, Vermeire P, Pride NB, et al. Optimal assessment & management of chronic obstructive pulmonary disease (COPD). Eur Respir J 1995; 8: 1398-1420.
9. Madison JM, Irwin RS. Chronic obstructive pulmonary disease. Lancet 1998; 352: 467-473.
10. Mobbs KJ, van Saene HKF, Sunderland D, et al. Oropharyngeal Gram-negative bacillary cariage: a survey of 120 healthy individuals. Chest 1999; 115: 1570-1576.
11. van Saene HKF, Silvestri L, Baines P. Definitions. In van Saene HKF, Silvestri L, de la Cal MA, eds. Infection Control in the Intensive Care Unit. Milan: 1st edn. Springer-verlag, 1998: 1-8.
12. Laforce FM, Hopkins J, Trow R et al. Human oral defences against Gram-negative rods. Am Rev Respir Dis 1976; 114: 929-935.
13. Macfarlane TW, Mason DK. Local environmental factors in host resistance to the commensal microflora of the mouth. In: MacPhee T, ed. Host Resistance to Commensal Bacteria. London: Churchill Livingstone, 1972: 64-75.
14. Ayars GH, Altam LC, Fretwell MD. Effect of decreased salivation and pH on the adherence of Klebsiella species to human buccal epithelial cells. Infect Immun 1982; 38: 179-182.
15. Bloomfield AL. The fate of bacteria introduced into the upper air passages. II. Bacillus coli and Staphylococcus albus. Bull Johns Hopkins Hasp 1920; 31: 14-19.
16. Dreizen S, Gilley EJ, Spies TD. A comparison of the prevailing cell types in saliva of persons with and without periodontal disease. Oral Surg 1956; 9: 278-283.
17. Brandtzaeg P, Fjellanger I, Gjeruldsen ST. Absorption of immunoglobin A onto oral bacteria in vivo. J Bacteriol 1968; 96: 242-249.
18. Sprunt K, Leidy G. The use of bacterial interference to prevent infection. Can J Microbiol 1988; 34: 332-338.
19. Dal Nogare AR, Toews GB, Pierce AK. Increased salivary elastase precedes Gram-negative bacillary colonisation in postoperative patients. Am Rev Respir Dis 1987; 135: 671-675.
20. Kleinegger CL, Lockhart SR, Vargas K et al. Frequency, intensity, species and strains of oral Candida vary as a function of host age. J Clin Microb 1996; 34: 2246-2254.
21. Wilkieson CP, Samaranayake LP, MacFarlane TW et al. Oral candidosis in the elderly in long term hospital care. J Oral Pathol Med 1991; 20: 13-16.
22. Leeper KV. Severe community-acquired pneumonia. Semin Respir Inject 1996; 11: 96-108.
23. Fagon J-Y, Chastre J. Severe exacerbations of COPD patients: the role of pulmonary infections. Semin Respir Infect 1996; 11: 109-118.
24. Potgieter PD, Hammond JMJ. Etiology and diagnosis of pneumonia requiring ICU admission. Chest 1992; 101: 199-203.
25. Gump DW, Phillips CA, Forsyth BR, et al. Role of infection in chronic bronchitis. Am Rev Respir Dis 1976; 113: 465-474.
26. Leroy O, Santre C, Beuscart C, et al. A five year study of severe community acquired pneumonia with emphasis on prognosis in patients admitted to an intensive care unit. Intens Care Med 1995; 21: 24-31.
27. Torres A, Dorca J, Zalacain R, et al. Community acquired pneumonia in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1996; 154: 1456-1461.
28. Moran JL, Green JV, Homan SD et al. Acute exacerbations of chronic obstructive pulmonary disease and mechanical ventilation; a reevaluation. Crit Care Med 1998; 26: 71-78.
29. Saint S, Bent S, Vittinghoff E et al. Antibiotics in chronic obstructive pulmonary disease exacerbations. JAMA 1995; 273: 957-960.
30. Fink MP, Snydman DR, Niederman MS, et al. Treatment of severe pneumonia in hospitalised patients: results of multicenter, randomized, double blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. Antimicrob Agents Chemother 1994; 38: 547-557.
31. van Uffelen R, van Saene HKF, Fidler V et al. Oropharyngeal flora as a source of bacteria colonizing the lower airways in patients on artificial ventilation. Intens Care Med 1984; 10: 233-237.
32. Eller J, Ede A, Schaberg T, et al. Infective exacerbation of chronic bronchitis. Chest 1998; 113: 1542-1548.